Written question asked by George Howarth (Labour) on Tuesday, 22 January 2002, in the House of Commons. It was due for an answer on Tuesday, 29 January 2002. It was answered by Baroness Smith of Malvern (Labour) on Tuesday, 29 January 2002 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what scientific advice he has received on the relative merits of (a) cell research and (b) the further development of pharmaceutical products in developing a cure for type 1 diabetes.

Answer: Mr. George Howarth: To ask the Secretary of State for Health what scientific advice he has received on the relative merits of (a) cell research and (b) the further development of pharmaceutical products in developing a cure for type 1 diabetes. [30544] Jacqui Smith: We have received no advice on the relative merits of cell research and the further development of pharmaceutical products in developing a cure for Type 1 diabetes. The Human Genetics Commission provides us with strategic advice on developments in human genetics and their social and ethical implications. To date, the Commission has given no advice relevant to cell research and diabetes. The Gene Therapy Advisory Committee has received no proposals for gene therapy research relating to diabetes and none is expected at present. We will, however, continue to monitor developments with interest.

Secondary information

Type: Written question
Reference: 30544; 379 c280-1W;379 c278-9W
Session: 2001-02
Subjects: Diabetes Genetics Medical treatments Research Human Genetics Commission
Link: View this Written question on www.publications.parliament.uk